Literature DB >> 2473024

Metaplastic carcinomas of the breast. II. Spindle cell carcinoma.

E S Wargotz1, P H Deos, H J Norris.   

Abstract

The clinical and pathologic features of 100 examples of spindle cell carcinoma (SpCC) of the breast are reported. Eighty-three neoplasms contained overt carcinoma; 72 had infiltrating ductal or intraductal carcinoma and in 11 the carcinomatous component was purely squamous. Seventeen neoplasms lacked overt carcinoma, but were identified as SpCC by immunoreactivity for keratin and the typical bland spindle cell proliferation forming a variable complex of fibrocollagenous stroma with feathered, myxoid, angioid, and storiform patterns. Areas of epithelium merging imperceptibly with the spindle cell component were commonly observed. Sixty neoplasms were studied by immunohistochemistry for the presence of keratin, epithelial membrane antigen (EMA), vimentin, S-100, and actin. The spindle cell component in 98% of SpCC was immunoreactive for keratin. Most were also immunoreactive for vimentin and actin, and in approximately one half, S-100 immunoreactivity was noted. These findings, in conjunction with histopathologic features, and ultrastructural observations from three cases, support myoepithelium as an integral component of SpCC. The cumulative 5-year survival rate for SpCC was 64%, better than survival rates usually reported for metaplastic carcinomas. Of 47 patients with axillary dissection, only 6% had metastases to axillary lymph nodes. Development of metastasis was an ominous sign as 29 of the 30 patients who developed metastases died from tumor. Local recurrence was not as ominous as only 29% who had only local recurrence subsequently died from tumor. The difference in size between tumors that recurred (mean, 5.0 cm) and those that did not (mean 3.7 cm), and the presence or absence of complete microscopic circumscription, were both significant prognostic factors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473024     DOI: 10.1016/0046-8177(89)90065-8

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  52 in total

1.  Triple negative mixed metaplastic breast carcinoma with squamous and spindle cells in an 84-year-old woman: a rare entity with unclear management strategy and poor prognosis.

Authors:  Srujitha Murukutla; Vijaya Raj Bhatt; Abhirami Vivekanandarajah; Cynara Coomer; Shilpi Gupta
Journal:  BMJ Case Rep       Date:  2012-02-25

Review 2.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

3.  Clinicopathologic features and outcomes of metaplastic breast carcinoma: comparison with invasive ductal carcinoma of the breast.

Authors:  Hyung Seok Park; Seho Park; Joo Hee Kim; Ju-Hyun Lee; So-Young Choi; Byeong-Woo Park; Kyong-Sik Lee
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

4.  Fine-needle aspiration cytology of metaplastic carcinoma of the breast.

Authors:  Philip C W Lui; Gary M K Tse; Puay Hoon Tan; Gita Jayaram; Thomas C Putti; Benjaporn Chaiwun; Norman H L Chan; Patrick P L Lau; Kong Ling Mak; Aye T Khin
Journal:  J Clin Pathol       Date:  2006-06-23       Impact factor: 3.411

Review 5.  Metaplastic breast cancer: clinical overview and molecular aberrations for potential targeted therapy.

Authors:  Sausan Abouharb; Stacy Moulder
Journal:  Curr Oncol Rep       Date:  2015-03       Impact factor: 5.075

6.  Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component.

Authors:  Bracha Erlanger Avigdor; Katie Beierl; Christopher D Gocke; Daniel J Zabransky; Karen Cravero; Kelly Kyker-Snowman; Berry Button; David Chu; Sarah Croessmann; Rory L Cochran; Roisin M Connolly; Ben H Park; Sarah J Wheelan; Ashley Cimino-Mathews
Journal:  Clin Cancer Res       Date:  2017-04-19       Impact factor: 12.531

7.  Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer.

Authors:  Reva K Basho; Clinton Yam; Michael Gilcrease; Rashmi K Murthy; Thorunn Helgason; Daniel D Karp; Funda Meric-Bernstam; Kenneth R Hess; Vicente Valero; Constance Albarracin; Jennifer K Litton; Mariana Chavez-MacGregor; David Hong; Razelle Kurzrock; Gabriel N Hortobagyi; Filip Janku; Stacy L Moulder
Journal:  Oncologist       Date:  2018-08-23

8.  Immunohistochemical study of metaplastic carcinoma and central acellular carcinoma of the breast: central acellular carcinoma is related to metaplastic carcinoma.

Authors:  Rin Yamaguchi; Maki Tanaka; Keiko Kondo; Toshiro Yokoyama; Ichiro Maeda; Shin-Ichi Tsuchiya; Miki Yamaguchi; Ryuji Takahashi; Yutaka Ogata; Hideyuki Abe; Jun Akiba; Osamu Nakashima; Masayoshi Kage; Hirohisa Yano
Journal:  Med Mol Morphol       Date:  2012-03-20       Impact factor: 2.309

Review 9.  A Comparative Review of Mixed Mammary Tumors in Mammals.

Authors:  Eman S A Saad; Jacqueline S Y Lam; Awf A Al-Khan; Mourad Tayebi; Michael J Day; Samantha J Richardson; Janine A Danks
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-11-28       Impact factor: 2.673

10.  Carcinosarcoma of the breast: two case reports and review of the literature.

Authors:  Kristi M Esses; Ramona M Hagmaier; Susan A Blanchard; John J Lazarchick; Adam I Riker
Journal:  Cases J       Date:  2009-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.